Neoadjuvant Therapy with Weekly Nanoparticle Albumin‐Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011‐02), a Multicenter, Non‐Randomized, Phase II Trial, with a Companion Biomarker Analysis

BACKGROUND. Nanoparticle albumin‐bound paclitaxel (nab‐Paclitaxel) is an alternative to standard taxanes for breast cancer (BC) treatment. We evaluated nab‐Paclitaxel efficacy as neoadjuvant treatment for early estrogen receptor‐positive (ER+), human epidermal growth factor receptor 2‐negative (HER2...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Martín, Miguel, Chacón, José I., Antón, Antonio, Plazaola, Arrate, García‐Martínez, Elena, Seguí, Miguel A., Sánchez‐Rovira, Pedro, Palacios, José, Calvo, Lourdes, Esteban, Carmen, Espinosa, Enrique, Barnadas, Agusti, Batista, Norberto, Guerrero, Angel, Muñoz, Montserrat, Romio, Estefania, Rodríguez‐Martín, César, Caballero, Rosalía, Casas, María I., Rojo, Federico, Carrasco, Eva, Antolín, Silvia
Format: Artigo
Sprog:Inglês
Udgivet: AlphaMed Press 2017
Fag:
Breast Cancer
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5679821/
https://ncbi.nlm.nih.gov/pubmed/28701571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0052
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker